Gesval
VC Fund
Liège, Belgium
Gesval is a VC fund in Liège focused on Biotechnology and Medical. A limited company of the University of Liège (ULiege).
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Gesval invests in
Stages Gesval invests in
Countries Gesval invests in
Round sizes
Round size
- Venture - Series Unknown
- $2.2M–$4.7M
Investment Focus
Industry
- Biotechnology 2 (40%)
- Medical 1 (20%)
- Software 1 (20%)
- Wellness 1 (20%)
- Power Grid 1 (20%)
Stage
- Venture - Series Unknown 2 (40%)
- Seed 1 (20%)
- Series A 1 (20%)
- Series C 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Hedera-22 expanded its scope to include the identification of natural products through the use of in-house bio-informatic prediction technologies. | $2.2M / Venture - Series Unknown / Aug 14, 2024 | ||
| Ampacimon develops dynamic line rating systems for transmission and distribution systems operators. Ampacimon’s products address grid infrastructure challenges such as aging assets, transmissions congestion, renewable integration, interconnectors. | $10.6M / Series C / Oct 16, 2023 | ||
| Ampacimon develops dynamic line rating systems for transmission and distribution systems operators. Ampacimon’s products address grid infrastructure challenges such as aging assets, transmissions congestion, renewable integration, interconnectors. | $4.7M / Venture - Series Unknown / Aug 26, 2020 | ||
| Phasya offers solutions for detecting drowsiness and measuring eye movements. These solutions are based on eye tracking technologies using eye images. Phasya also develops solutions for detecting various physiological and cognitive states such as stress, attention, cognitive load, and mind wandering.Phasya solutions can be used in variousapplications such as safety, medical diagnosis, and research. We have notably specific solutions and developments for driver monitoring applications.Indeed physiological and cognitive states such as drowsiness influence the ability of an individual to perform a task or to make a decision. Furthermore the measurement of ocular parameters enables one to understand the brain activity and gaze behavior. | $1.1M / Seed / Jan 21, 2019 | ||
| Cell Matters specializes in cell therapy productivity, turning cryopreservation into a competitive advantage. It offers an integrated set of GMP services, in line with regulatory, quality, and GMP requirements of the cell therapy industry. | $876.4K / Series A / Jan 23, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Gesval invest in?
Gesval invests primarily in Biotechnology, Medical and Software startups, most often at Venture - Series Unknown and Seed stage. Most of the 5 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Gesval invest in?
Gesval typically joins rounds of $2.2M–$4.7M at Venture - Series Unknown. These are whole funding-round sizes, not Gesval's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Gesval took part in.
When did Gesval last invest?
The most recent investment recorded for Gesval closed in Aug 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
